"Die Zentralklinik Bad Berka gehört zu den modernsten und architektonisch schönsten Kliniken Deutschlands. Außerdem ist die Zentralklinik Akademisches Lehrkrankenhaus des Universitätsklinikums Jena. Als überregionales Schwerpunktversorgungskrankenhaus mit 21 Fachkliniken und Zentren sowie einem interdisziplinären Diagnostikum mit hochqualifizierten Ärzten und geschultem Pflegepersonal versorgen wir jährlich rund 43.000 Patienten aus ganz Deutschland und dem Ausland. Insgesamt verfügen wir in unserem landschaftlich reizvoll gelegenen Haus über 647 Planbetten. Die Zentralklinik ist mit ca. 1.800 Mitarbeitern der größte Arbeitgeber der Region Weimarer Land."

During the past decade, Zentralklinik Bad Berka GmbH; Abteilung Onkologie und Hämatologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Zentralklinik Bad Berka GmbH; Abteilung Onkologie und Hämatologie" are "Non-Small Cell Lung Cancer" (1 trials) and "Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Zentralklinik Bad Berka GmbH; Abteilung Onkologie und Hämatologie" in a lesser frequency.

Most popular intervention types in "Zentralklinik Bad Berka GmbH; Abteilung Onkologie und Hämatologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Alectinib" (1 trials), "Docetaxel" (1 trials), "Pemetrexed" (1 trials), "Placebo" (1 trials) and "bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Zentralklinik Bad Berka GmbH; Abteilung Onkologie und Hämatologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Zentralklinik Bad Berka GmbH; Abteilung Onkologie und Hämatologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Zentralklinik Bad Berka GmbH; Abteilung Onkologie und Hämatologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Zentralklinik Bad Berka GmbH; Abteilung Onkologie und Hämatologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".